The global market for Embolization Particle was estimated to be worth US$ 2012.7 million in 2023 and is forecast to a readjusted size of US$ 5248.9 million by 2030 with a CAGR of 14.5% during the forecast period 2024-2030

Embolization Particle - Market

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Embolization Particle, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Embolization Particle by region & country, by Type, and by Application.

The Embolization Particle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolization Particle.

Market Segmentation

Scope of Embolization Particle - Market Report

Report Metric	Details
Report Name	Embolization Particle - Market
Forecasted market size in 2030	US$ 5248.9 million
CAGR	14.5%
Forecasted years	2024 - 2030
Segment by Type:	Microspheres Particles (e.g. PVA Particles, Gelfoam Particles) Drug-eluting Beads (DEBs) Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segment by Application	Uterine Fibroid Embolization Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Liver Tumor Embolization Trauma Embolization Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Embolization Particle in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Embolization Particle - Market size in 2030?

Ans: The Embolization Particle - Market size in 2030 will be US$ 5248.9 million.

What is the Embolization Particle - Market share by region?

Ans: It was followed by Europe with 30%.

What is the market share of major companies in Embolization Particle - Market?

Ans: Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.

Who are the main players in the Embolization Particle - Market report?

Ans: The main players in the Embolization Particle - Market are Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials B.V., Alicon

What are the Application segmentation covered in the Embolization Particle - Market report?

Ans: The Applications covered in the Embolization Particle - Market report are Uterine Fibroid Embolization, Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH), Liver Tumor Embolization, Trauma Embolization, Others

What are the Type segmentation covered in the Embolization Particle - Market report?

Ans: The Types covered in the Embolization Particle - Market report are Microspheres, Particles (e.g. PVA Particles, Gelfoam Particles), Drug-eluting Beads (DEBs), Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

1 Market Overview

1.1 Embolization Particle Product Introduction

1.2 Global Embolization Particle Market Size Forecast

1.2.1 Global Embolization Particle Sales Value (2019-2030)

1.2.2 Global Embolization Particle Sales Volume (2019-2030)

1.2.3 Global Embolization Particle Sales Price (2019-2030)

1.3 Embolization Particle Market Trends & Drivers

1.3.1 Embolization Particle Industry Trends

1.3.2 Embolization Particle Market Drivers & Opportunity

1.3.3 Embolization Particle Market Challenges

1.3.4 Embolization Particle Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Embolization Particle Players Revenue Ranking (2023)

2.2 Global Embolization Particle Revenue by Company (2019-2024)

2.3 Global Embolization Particle Players Sales Volume Ranking (2023)

2.4 Global Embolization Particle Sales Volume by Company Players (2019-2024)

2.5 Global Embolization Particle Average Price by Company (2019-2024)

2.6 Key Manufacturers Embolization Particle Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Embolization Particle Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Embolization Particle

2.9 Embolization Particle Market Competitive Analysis

2.9.1 Embolization Particle Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Embolization Particle Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolization Particle as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Microspheres

3.1.2 Particles (e.g. PVA Particles, Gelfoam Particles)

3.1.3 Drug-eluting Beads (DEBs)

3.1.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

3.2 Global Embolization Particle Sales Value by Type

3.2.1 Global Embolization Particle Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Embolization Particle Sales Value, by Type (2019-2030)

3.2.3 Global Embolization Particle Sales Value, by Type (%) (2019-2030)

3.3 Global Embolization Particle Sales Volume by Type

3.3.1 Global Embolization Particle Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Embolization Particle Sales Volume, by Type (2019-2030)

3.3.3 Global Embolization Particle Sales Volume, by Type (%) (2019-2030)

3.4 Global Embolization Particle Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Uterine Fibroid Embolization

4.1.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

4.1.3 Liver Tumor Embolization

4.1.4 Trauma Embolization

4.1.5 Others

4.2 Global Embolization Particle Sales Value by Application

4.2.1 Global Embolization Particle Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Embolization Particle Sales Value, by Application (2019-2030)

4.2.3 Global Embolization Particle Sales Value, by Application (%) (2019-2030)

4.3 Global Embolization Particle Sales Volume by Application

4.3.1 Global Embolization Particle Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Embolization Particle Sales Volume, by Application (2019-2030)

4.3.3 Global Embolization Particle Sales Volume, by Application (%) (2019-2030)

4.4 Global Embolization Particle Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Embolization Particle Sales Value by Region

5.1.1 Global Embolization Particle Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Embolization Particle Sales Value by Region (2019-2024)

5.1.3 Global Embolization Particle Sales Value by Region (2025-2030)

5.1.4 Global Embolization Particle Sales Value by Region (%), (2019-2030)

5.2 Global Embolization Particle Sales Volume by Region

5.2.1 Global Embolization Particle Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Embolization Particle Sales Volume by Region (2019-2024)

5.2.3 Global Embolization Particle Sales Volume by Region (2025-2030)

5.2.4 Global Embolization Particle Sales Volume by Region (%), (2019-2030)

5.3 Global Embolization Particle Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Embolization Particle Sales Value, 2019-2030

5.4.2 North America Embolization Particle Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Embolization Particle Sales Value, 2019-2030

5.5.2 Europe Embolization Particle Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Embolization Particle Sales Value, 2019-2030

5.6.2 Asia Pacific Embolization Particle Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Embolization Particle Sales Value, 2019-2030

5.7.2 South America Embolization Particle Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Embolization Particle Sales Value, 2019-2030

5.8.2 Middle East & Africa Embolization Particle Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Embolization Particle Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Embolization Particle Sales Value

6.2.1 Key Countries/Regions Embolization Particle Sales Value, 2019-2030

6.2.2 Key Countries/Regions Embolization Particle Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Embolization Particle Sales Value, 2019-2030

6.3.2 United States Embolization Particle Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Embolization Particle Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Embolization Particle Sales Value, 2019-2030

6.4.2 Europe Embolization Particle Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Embolization Particle Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Embolization Particle Sales Value, 2019-2030

6.5.2 China Embolization Particle Sales Value by Type (%), 2023 VS 2030

6.5.3 China Embolization Particle Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Embolization Particle Sales Value, 2019-2030

6.6.2 Japan Embolization Particle Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Embolization Particle Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Embolization Particle Sales Value, 2019-2030

6.7.2 South Korea Embolization Particle Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Embolization Particle Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Embolization Particle Sales Value, 2019-2030

6.8.2 Southeast Asia Embolization Particle Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Embolization Particle Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Embolization Particle Sales Value, 2019-2030

6.9.2 India Embolization Particle Sales Value by Type (%), 2023 VS 2030

6.9.3 India Embolization Particle Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Sirtex Medical

7.1.1 Sirtex Medical Company Information

7.1.2 Sirtex Medical Introduction and Business Overview

7.1.3 Sirtex Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Sirtex Medical Embolization Particle Product Offerings

7.1.5 Sirtex Medical Recent Development

7.2 Merit Medical

7.2.1 Merit Medical Company Information

7.2.2 Merit Medical Introduction and Business Overview

7.2.3 Merit Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Merit Medical Embolization Particle Product Offerings

7.2.5 Merit Medical Recent Development

7.3 Cook Medical

7.3.1 Cook Medical Company Information

7.3.2 Cook Medical Introduction and Business Overview

7.3.3 Cook Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Cook Medical Embolization Particle Product Offerings

7.3.5 Cook Medical Recent Development

7.4 BTG Medical

7.4.1 BTG Medical Company Information

7.4.2 BTG Medical Introduction and Business Overview

7.4.3 BTG Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.4.4 BTG Medical Embolization Particle Product Offerings

7.4.5 BTG Medical Recent Development

7.5 Boston Scientific Corporation

7.5.1 Boston Scientific Corporation Company Information

7.5.2 Boston Scientific Corporation Introduction and Business Overview

7.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Boston Scientific Corporation Embolization Particle Product Offerings

7.5.5 Boston Scientific Corporation Recent Development

7.6 Terumo Corporation

7.6.1 Terumo Corporation Company Information

7.6.2 Terumo Corporation Introduction and Business Overview

7.6.3 Terumo Corporation Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Terumo Corporation Embolization Particle Product Offerings

7.6.5 Terumo Corporation Recent Development

7.7 HENGRUI Medical

7.7.1 HENGRUI Medical Company Information

7.7.2 HENGRUI Medical Introduction and Business Overview

7.7.3 HENGRUI Medical Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.7.4 HENGRUI Medical Embolization Particle Product Offerings

7.7.5 HENGRUI Medical Recent Development

7.8 INterface BIOmaterials B.V.

7.8.1 INterface BIOmaterials B.V. Company Information

7.8.2 INterface BIOmaterials B.V. Introduction and Business Overview

7.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.8.4 INterface BIOmaterials B.V. Embolization Particle Product Offerings

7.8.5 INterface BIOmaterials B.V. Recent Development

7.9 Alicon

7.9.1 Alicon Company Information

7.9.2 Alicon Introduction and Business Overview

7.9.3 Alicon Embolization Particle Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Alicon Embolization Particle Product Offerings

7.9.5 Alicon Recent Development

8 Industry Chain Analysis

8.1 Embolization Particle Industrial Chain

8.2 Embolization Particle Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Embolization Particle Sales Model

8.5.2 Sales Channel

8.5.3 Embolization Particle Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

INterface BIOmaterials B.V.

Alicon

Boston Scientific Corporation

List of Tables

Table 1. Embolization Particle Market Trends

Table 2. Embolization Particle Market Drivers & Opportunity

Table 3. Embolization Particle Market Challenges

Table 4. Embolization Particle Market Restraints

Table 5. Global Embolization Particle Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Embolization Particle Revenue Market Share by Company (2019-2024)

Table 7. Global Embolization Particle Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Embolization Particle Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Embolization Particle Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Embolization Particle Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Embolization Particle Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Embolization Particle

Table 13. Global Embolization Particle Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolization Particle as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Embolization Particle Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Embolization Particle Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Embolization Particle Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Embolization Particle Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Embolization Particle Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Embolization Particle Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Embolization Particle Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Embolization Particle Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Embolization Particle Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Embolization Particle Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Embolization Particle Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Embolization Particle Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Embolization Particle Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Embolization Particle Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Embolization Particle Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Embolization Particle Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Embolization Particle Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Embolization Particle Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Embolization Particle Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Embolization Particle Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Embolization Particle Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Embolization Particle Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Embolization Particle Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Embolization Particle Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Embolization Particle Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Embolization Particle Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Embolization Particle Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Embolization Particle Sales Value by Region (2019-2024) & (%)

Table 44. Global Embolization Particle Sales Value by Region (2025-2030) & (%)

Table 45. Global Embolization Particle Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Embolization Particle Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Embolization Particle Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Embolization Particle Sales Volume by Region (2019-2024) & (%)

Table 49. Global Embolization Particle Sales Volume by Region (2025-2030) & (%)

Table 50. Global Embolization Particle Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Embolization Particle Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Embolization Particle Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Embolization Particle Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Embolization Particle Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Embolization Particle Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Embolization Particle Sales Volume, (2025-2030) & (K Units)

Table 57. Sirtex Medical Company Information

Table 58. Sirtex Medical Introduction and Business Overview

Table 59. Sirtex Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Sirtex Medical Embolization Particle Product Offerings

Table 61. Sirtex Medical Recent Development

Table 62. Merit Medical Company Information

Table 63. Merit Medical Introduction and Business Overview

Table 64. Merit Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Merit Medical Embolization Particle Product Offerings

Table 66. Merit Medical Recent Development

Table 67. Cook Medical Company Information

Table 68. Cook Medical Introduction and Business Overview

Table 69. Cook Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Cook Medical Embolization Particle Product Offerings

Table 71. Cook Medical Recent Development

Table 72. BTG Medical Company Information

Table 73. BTG Medical Introduction and Business Overview

Table 74. BTG Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. BTG Medical Embolization Particle Product Offerings

Table 76. BTG Medical Recent Development

Table 77. Boston Scientific Corporation Company Information

Table 78. Boston Scientific Corporation Introduction and Business Overview

Table 79. Boston Scientific Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Boston Scientific Corporation Embolization Particle Product Offerings

Table 81. Boston Scientific Corporation Recent Development

Table 82. Terumo Corporation Company Information

Table 83. Terumo Corporation Introduction and Business Overview

Table 84. Terumo Corporation Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Terumo Corporation Embolization Particle Product Offerings

Table 86. Terumo Corporation Recent Development

Table 87. HENGRUI Medical Company Information

Table 88. HENGRUI Medical Introduction and Business Overview

Table 89. HENGRUI Medical Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. HENGRUI Medical Embolization Particle Product Offerings

Table 91. HENGRUI Medical Recent Development

Table 92. INterface BIOmaterials B.V. Company Information

Table 93. INterface BIOmaterials B.V. Introduction and Business Overview

Table 94. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. INterface BIOmaterials B.V. Embolization Particle Product Offerings

Table 96. INterface BIOmaterials B.V. Recent Development

Table 97. Alicon Company Information

Table 98. Alicon Introduction and Business Overview

Table 99. Alicon Embolization Particle Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Alicon Embolization Particle Product Offerings

Table 101. Alicon Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Embolization Particle Downstream Customers

Table 105. Embolization Particle Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Embolization Particle Product Picture

Figure 2. Global Embolization Particle Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Embolization Particle Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Embolization Particle Sales Volume (2019-2030) & (K Units)

Figure 5. Global Embolization Particle Sales Price (2019-2030) & (USD/Unit)

Figure 6. Embolization Particle Report Years Considered

Figure 7. Global Embolization Particle Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Embolization Particle Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Embolization Particle Revenue in 2023

Figure 10. Embolization Particle Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Microspheres Picture

Figure 12. Particles (e.g. PVA Particles, Gelfoam Particles) Picture

Figure 13. Drug-eluting Beads (DEBs) Picture

Figure 14. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Picture

Figure 15. Global Embolization Particle Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 16. Global Embolization Particle Sales Value Market Share by Type, 2023 & 2030

Figure 17. Global Embolization Particle Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 18. Global Embolization Particle Sales Volume Market Share by Type, 2023 & 2030

Figure 19. Global Embolization Particle Price by Type (2019-2030) & (USD/Unit)

Figure 20. Product Picture of Uterine Fibroid Embolization

Figure 21. Product Picture of Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Figure 22. Product Picture of Liver Tumor Embolization

Figure 23. Product Picture of Trauma Embolization

Figure 24. Product Picture of Others

Figure 25. Global Embolization Particle Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 26. Global Embolization Particle Sales Value Market Share by Application, 2023 & 2030

Figure 27. Global Embolization Particle Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 28. Global Embolization Particle Sales Volume Market Share by Application, 2023 & 2030

Figure 29. Global Embolization Particle Price by Application (2019-2030) & (USD/Unit)

Figure 30. North America Embolization Particle Sales Value (2019-2030) & (US$ Million)

Figure 31. North America Embolization Particle Sales Value by Country (%), 2023 VS 2030

Figure 32. Europe Embolization Particle Sales Value (2019-2030) & (US$ Million)

Figure 33. Europe Embolization Particle Sales Value by Country (%), 2023 VS 2030

Figure 34. Asia Pacific Embolization Particle Sales Value (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Embolization Particle Sales Value by Country (%), 2023 VS 2030

Figure 36. South America Embolization Particle Sales Value (2019-2030) & (US$ Million)

Figure 37. South America Embolization Particle Sales Value by Country (%), 2023 VS 2030

Figure 38. Middle East & Africa Embolization Particle Sales Value (2019-2030) & (US$ Million)

Figure 39. Middle East & Africa Embolization Particle Sales Value by Country (%), 2023 VS 2030

Figure 40. Key Countries/Regions Embolization Particle Sales Value (%), (2019-2030)

Figure 41. Key Countries/Regions Embolization Particle Sales Volume (%), (2019-2030)

Figure 42. United States Embolization Particle Sales Value, (2019-2030) & (US$ Million)

Figure 43. United States Embolization Particle Sales Value by Type (%), 2023 VS 2030

Figure 44. United States Embolization Particle Sales Value by Application (%), 2023 VS 2030

Figure 45. Europe Embolization Particle Sales Value, (2019-2030) & (US$ Million)

Figure 46. Europe Embolization Particle Sales Value by Type (%), 2023 VS 2030

Figure 47. Europe Embolization Particle Sales Value by Application (%), 2023 VS 2030

Figure 48. China Embolization Particle Sales Value, (2019-2030) & (US$ Million)

Figure 49. China Embolization Particle Sales Value by Type (%), 2023 VS 2030

Figure 50. China Embolization Particle Sales Value by Application (%), 2023 VS 2030

Figure 51. Japan Embolization Particle Sales Value, (2019-2030) & (US$ Million)

Figure 52. Japan Embolization Particle Sales Value by Type (%), 2023 VS 2030

Figure 53. Japan Embolization Particle Sales Value by Application (%), 2023 VS 2030

Figure 54. South Korea Embolization Particle Sales Value, (2019-2030) & (US$ Million)

Figure 55. South Korea Embolization Particle Sales Value by Type (%), 2023 VS 2030

Figure 56. South Korea Embolization Particle Sales Value by Application (%), 2023 VS 2030

Figure 57. Southeast Asia Embolization Particle Sales Value, (2019-2030) & (US$ Million)

Figure 58. Southeast Asia Embolization Particle Sales Value by Type (%), 2023 VS 2030

Figure 59. Southeast Asia Embolization Particle Sales Value by Application (%), 2023 VS 2030

Figure 60. India Embolization Particle Sales Value, (2019-2030) & (US$ Million)

Figure 61. India Embolization Particle Sales Value by Type (%), 2023 VS 2030

Figure 62. India Embolization Particle Sales Value by Application (%), 2023 VS 2030

Figure 63. Embolization Particle Industrial Chain

Figure 64. Embolization Particle Manufacturing Cost Structure

Figure 65. Channels of Distribution (Direct Sales, and Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Artery Imaging Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37R6046

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global ECG Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23S9116

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Decentralized & POC Coagulation Testing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7S6333

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Transcatheter Aortic Valve Implantation (TAVI) System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-37M13084

Sun Apr 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions